Reminder: Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in Vienna, Austria
Posted on: Monday, 13 July 2009, 07:00 CDT
COLUMBIA, Md., July 13/PRNewswire-FirstCall/ --Martek Biosciences Corporation (Nasdaq: MATK) will conduct a conference call for investors to discussDHA research recently presented at the International Conference on Alzheimer's Disease. The call will take place July 13, 2009, at approximately 9 a.m. Eastern Time (ET). All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com.
An archived webcast of the conference call will be available on the Martek's website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 or 402-977-9140 and entering pass code 214 31512.
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.
CONTACT Kyle Stults Investor Relations (410) 740-0081 investors@martek.comSOURCE Martek Biosciences Corporation
Source: PR Newswire
Related Articles
- Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in Vienna, Austria
- BIO CEO & Investor Conference Therapeutic Workshops Highlight Innovative Trends in Biotech Therapies
- Energy Conversion Devices to Hold Corporate-Update Conference Call for Investors and Analysts on Thursday, April 19, 2007
- Hollis-Eden Pharmaceuticals Announces Second Quarter 2006 Conference Call and Investor Conference Webcasts
- Hollis-Eden Pharmaceuticals Announces First Quarter 2006 Conference Call and Investor Conference Webcasts
- Genaera Corporation to Host Investor Conference Call to Review Business and Clinical Strategies
- Hollis-Eden Pharmaceuticals Announces Third Quarter 2005 Conference Call and Investor Conference Webcast
- Phantom Fiber Corporation Announces Investor Conference Call, Hosted By Company President & CEO, Jeff Halloran
- The Immune Response Corporation Updates Business and Clinical Strategies on Investor Conference Call
 |
 |
User Comments (0)
RSS Feeds